OOIR: Observatory of International Research

Papers

(The H4-Index of Current Treatment Options in Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Role of Metastasis-Directed Therapy in Genitourinary Cancers	152
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer	110
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia	84
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies	70
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma	60
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead	55
An Update on Temporal Bone Paragangliomas	52
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions	51
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes	48
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect	45
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer	42
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors	40
Approach to Localized Squamous Cell Cancer of the Esophagus	40
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers	38
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?	37
Management of Fatigue in Patients with Advanced Cancer	33
Small Cell Lung Cancer—An Update on Chemotherapy Resistance	33
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma	33
The Role of Nursing in the Delivery of Cardio-Oncology	32
Regorafenib for the Treatment of Sarcoma	32
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations	31
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer	31
Advances in Targeted Therapy for Metastatic Prostate Cancer	29
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer	29
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities	28

Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia	27
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs	27
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements	27